Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
Gross Profit
Prestige Consumer Healthcare Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Gross Profit
$626.4m
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
6%
|
|
Johnson & Johnson
NYSE:JNJ
|
Gross Profit
$57.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
1%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Gross Profit
$34.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
16%
|
CAGR 10-Years
11%
|
|
Pfizer Inc
NYSE:PFE
|
Gross Profit
$40.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
5%
|
CAGR 10-Years
0%
|
|
Merck & Co Inc
NYSE:MRK
|
Gross Profit
$44.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
9%
|
CAGR 10-Years
5%
|
|
Eli Lilly and Co
NYSE:LLY
|
Gross Profit
$27B
|
CAGR 3-Years
12%
|
CAGR 5-Years
10%
|
CAGR 10-Years
4%
|
See Also
What is Prestige Consumer Healthcare Inc's Gross Profit?
Gross Profit
626.4m
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Gross Profit amounts to 626.4m USD.
What is Prestige Consumer Healthcare Inc's Gross Profit growth rate?
Gross Profit CAGR 10Y
6%
Over the last year, the Gross Profit growth was 1%. The average annual Gross Profit growth rates for Prestige Consumer Healthcare Inc have been 4% over the past three years , 2% over the past five years , and 6% over the past ten years .